Summit Therapeutics (SMMT) Shares Issued (2016 - 2025)
Historic Shares Issued for Summit Therapeutics (SMMT) over the last 10 years, with Q2 2025 value amounting to $1.7 million.
- Summit Therapeutics' Shares Issued fell 9916.95% to $1.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 9835.7%. This contributed to the annual value of $434.9 million for FY2024, which is 859720.0% up from last year.
- Summit Therapeutics' Shares Issued amounted to $1.7 million in Q2 2025, which was down 9916.95% from $5.7 million recorded in Q1 2025.
- Summit Therapeutics' Shares Issued's 5-year high stood at $235.0 million during Q3 2024, with a 5-year trough of -$103.8 million in Q3 2023.
- For the 5-year period, Summit Therapeutics' Shares Issued averaged around $37.3 million, with its median value being $2.9 million (2023).
- Over the last 5 years, Summit Therapeutics' Shares Issued had its largest YoY gain of 5588181.82% in 2023, and its largest YoY loss of 20400.05% in 2023.
- Summit Therapeutics' Shares Issued (Quarter) stood at $74.1 million in 2021, then plummeted by 234.41% to -$99.6 million in 2022, then surged by 104.14% to $4.1 million in 2023, then tumbled by 102.45% to -$101000.0 in 2024, then soared by 1740.59% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q2 2025, $5.7 million for Q1 2025, and -$101000.0 during Q4 2024.